The Commonwealth Foundation for Cancer Research has pledged $25 million to the Bridge Project, a collaborative research program of Dana-Farber/Harvard Cancer Center (DF/HCC) and the Koch Institute for Integrative Cancer Research at MIT (KI), to transform drug discovery and early-stage development.
As part of this commitment to the Bridge Project, The Commonwealth Foundation gift will propel “Expansion Grants,” which fund projects being readied for clinical testing or that are already in the clinic. It will also place a significant focus on projects that accelerate therapeutic drug development, stimulating research on traditionally challenging classes of cancer drug targets and/or on more conventional targets found in rarer forms of cancer.
